MOVE Share Price Performance
CHF 130.20
-8.80 (-6.33%)
27.3% undervalued intrinsic discount
CHF 179.08
Fair Value
Price CHF 130.20
AnalystConsensusTarget CHF 179.08
Fair ValueCHF 179.08
Share Pricen/a
Narrative Update • Jun 23
Medacta Group SA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
MOVE Community Narratives
AN
Fair Value
·Fair Value CHF 179.08 27.3% undervalued intrinsic discount
Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Earnings Guidance And Updated Outlook Will Drive Expansion Across New Markets
Medacta is pushing into new regions and leaning on new knee and sports-medicine products to win more surgeons and hospitals, with added momentum from targeted acquisitions. The big question is whether heavier spending, tougher competition, and currency swings will slow the payoff.Read more
AN
CHF 179.08
27.3% undervalued intrinsic discount
Fair Value
Revenue
11.91% p.a.
Profit Margin
14.38%
Future PE
30.45x
Price in 2029
CHF 196.08
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
MOVE: Insider Alignment And Earnings Quality Will Support Future Upside Potential
Fair Value: CHF 179.08 27.3% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Medacta Group SA Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 09, 2026
- 4.79
- 67.07%
- 13.96%
- 44.9%
About MOVE
- Founded
- 1958
- Employees
- 2036
- CEO
- WebsiteView website
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
